1. Home
  2. MD vs AGIO Comparison

MD vs AGIO Comparison

Compare MD & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pediatrix Medical Group Inc.

MD

Pediatrix Medical Group Inc.

HOLD

Current Price

$26.77

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$35.99

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MD
AGIO
Founded
1979
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Hospital/Nursing Management
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.3B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
MD
AGIO
Price
$26.77
$35.99
Analyst Decision
Hold
Buy
Analyst Count
4
8
Target Price
$20.50
$38.88
AVG Volume (30 Days)
737.9K
1.0M
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
263.03
N/A
EPS
0.36
N/A
Revenue
$1,913,849,000.00
$43,011,000.00
Revenue This Year
$3.72
$76.75
Revenue Next Year
$2.62
$170.73
P/E Ratio
$72.61
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.84
$22.24
52 Week High
$28.86
$46.00

Technical Indicators

Market Signals
Indicator
MD
AGIO
Relative Strength Index (RSI) 59.86 44.85
Support Level $19.93 $26.16
Resistance Level $28.86 $36.07
Average True Range (ATR) 0.92 1.75
MACD -0.07 -0.83
Stochastic Oscillator 92.06 6.93

Price Performance

Historical Comparison
MD
AGIO

About MD Pediatrix Medical Group Inc.

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: